RT Journal Article
SR Electronic
T1 727 Topline safety and efficacy update of SUPLEXA-101, a first-in-human, single agent study of SUPLEXA therapeutic cells in 28 patients with metastatic solid tumours
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A822
OP A822
DO 10.1136/jitc-2023-SITC2023.0727
VO 11
IS Suppl 1
A1 Joshi, Rohit
A1 Goh, Jeffrey
A1 Gargosky, Sharron
A1 Kitchenadasse, Ganessan
A1 Atkinson, Victoria
A1 Joubert, Warren
A1 Kwatra, Vineet
A1 Okera, Meena
A1 Bishnoi, Sarwan
A1 Nisyrios, George
A1 Lederer, James A
A1 Borriello, Frank
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A822.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.